Mucosolvan Long Effect (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosolvan Long Effect, is a mucolytic presented as an oral dosage form for oral use. It helps reduce thickened respiratory secretions in patients with acute or chronic bronchial conditions and other mucus‑related respiratory infections.

GNH USA supplies Mucosolvan Long Effect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable global logistics for consistent product availability and timely delivery to meet clinical demand.

Ambroxol is a mucolytic that acts on respiratory conditions characterized by thickened mucus.

Acute bronchitis: facilitates expectoration and eases cough by thinning airway secretions. Chronic bronchitis: improves mucus clearance and reduces cough frequency. Chronic obstructive pulmonary disease (COPD): helps maintain airway patency by decreasing sputum viscosity. Respiratory tract infections with excessive mucus: supports symptom relief by promoting easier expectoration.

Adverse reactions may occur with ambroxol use and are reported with varying frequency.

Common Side Effects: - Nausea or upset stomach. - Diarrhea or loose stools. - Skin rash or mild itching. - Taste disturbances or bitter taste. - Headache. - Dizziness.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema). - Hepatotoxicity manifested by elevated liver enzymes. - Acute pancreatitis. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hematologic abnormalities (e.g., neutropenia).

Before initiating therapy, consider the following safety measures.

Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. Breastfeeding: assess risk versus benefit, as the drug may be excreted in milk. Renal impairment: monitor renal function and adjust therapy if necessary. Hepatic impairment: use with caution and observe liver function tests. Drug interactions: review concomitant medications for possible interactions. Store below 25°C: keep in the original pack, protect from moisture.

Ambroxol may interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Anticholinergic agents: may reduce mucolytic efficacy. - Bronchodilators (high doses): potential additive cardiovascular effects.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates: ambroxol can inhibit metabolism, increasing plasma levels. - Anticoagulants (e.g., warfarin): monitor INR as ambroxol may affect clotting parameters. - Other mucolytics: combined use may increase gastrointestinal irritation.